中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
CHINESE JOURNAL OF EXPERIMENTAL SURGERY
2008年
4期
519-522
,共4页
王效民%傅锦波%黄小进%罗琪%李岗山%卢明珠%余德
王效民%傅錦波%黃小進%囉琪%李崗山%盧明珠%餘德
왕효민%부금파%황소진%라기%리강산%로명주%여덕
骨髓移植%肝移植%动物模型
骨髓移植%肝移植%動物模型
골수이식%간이식%동물모형
Bone marrow transplantation%Liver transplantation%Model,animal
目的 通过建立同种异体大鼠骨髓及肝联合移植动物模型,探讨提高大鼠肝移植模型的稳定性和存活率的方法及可行性.方法 将SD大鼠(♂)、Wistar大鼠(♀)分成三组:Ⅰ组大鼠Kamada"二袖套法"行SD→Wistar大鼠肝移植;Ⅱ组Wistar大鼠(♀)TBI(11 Gy),4 h后输人SD大鼠(♂)BMC(8×107),28 d后Kamada"二袖套法"行SD→Wistar大鼠肝移植;Ⅲ组Wistar大鼠(♀)TBI(7 Gy),4h后输入SD大鼠(♂)BMC(8×107),2 d后CTX(50 mg/kg体重)腹腔注射,28 d后Kamada"二袖套法"行SD→Wistar大鼠肝移植.分别于BMT后10、20 d通过PCR方法检测Ⅱ组和Ⅲ组Wistar大鼠体内的SD大鼠源性Y染色体特异性片段.并比较3组大鼠肝移植术后1周生存率、生存状况及生存时间.结果 Ⅱ组和Ⅲ组大鼠外周血均检测出SD大鼠源性嵌合体.DTH检查显示对SD大鼠产生免疫耐受.肝移植结果显示,Ⅰ组大鼠均在4~5 d死亡,而Ⅱ组和Ⅲ组大鼠1周存活率为80.0%和84.2%,但Ⅱ组的生存状况不如Ⅲ组.结论 应用7GyTBI+CTX+供体BMT可成功建立同种异体大鼠嵌合体模型,诱导特异性免疫耐受,大大提高肝移植术后大鼠的生存状况及生存时间.
目的 通過建立同種異體大鼠骨髓及肝聯閤移植動物模型,探討提高大鼠肝移植模型的穩定性和存活率的方法及可行性.方法 將SD大鼠(♂)、Wistar大鼠(♀)分成三組:Ⅰ組大鼠Kamada"二袖套法"行SD→Wistar大鼠肝移植;Ⅱ組Wistar大鼠(♀)TBI(11 Gy),4 h後輸人SD大鼠(♂)BMC(8×107),28 d後Kamada"二袖套法"行SD→Wistar大鼠肝移植;Ⅲ組Wistar大鼠(♀)TBI(7 Gy),4h後輸入SD大鼠(♂)BMC(8×107),2 d後CTX(50 mg/kg體重)腹腔註射,28 d後Kamada"二袖套法"行SD→Wistar大鼠肝移植.分彆于BMT後10、20 d通過PCR方法檢測Ⅱ組和Ⅲ組Wistar大鼠體內的SD大鼠源性Y染色體特異性片段.併比較3組大鼠肝移植術後1週生存率、生存狀況及生存時間.結果 Ⅱ組和Ⅲ組大鼠外週血均檢測齣SD大鼠源性嵌閤體.DTH檢查顯示對SD大鼠產生免疫耐受.肝移植結果顯示,Ⅰ組大鼠均在4~5 d死亡,而Ⅱ組和Ⅲ組大鼠1週存活率為80.0%和84.2%,但Ⅱ組的生存狀況不如Ⅲ組.結論 應用7GyTBI+CTX+供體BMT可成功建立同種異體大鼠嵌閤體模型,誘導特異性免疫耐受,大大提高肝移植術後大鼠的生存狀況及生存時間.
목적 통과건립동충이체대서골수급간연합이식동물모형,탐토제고대서간이식모형적은정성화존활솔적방법급가행성.방법 장SD대서(♂)、Wistar대서(♀)분성삼조:Ⅰ조대서Kamada"이수투법"행SD→Wistar대서간이식;Ⅱ조Wistar대서(♀)TBI(11 Gy),4 h후수인SD대서(♂)BMC(8×107),28 d후Kamada"이수투법"행SD→Wistar대서간이식;Ⅲ조Wistar대서(♀)TBI(7 Gy),4h후수입SD대서(♂)BMC(8×107),2 d후CTX(50 mg/kg체중)복강주사,28 d후Kamada"이수투법"행SD→Wistar대서간이식.분별우BMT후10、20 d통과PCR방법검측Ⅱ조화Ⅲ조Wistar대서체내적SD대서원성Y염색체특이성편단.병비교3조대서간이식술후1주생존솔、생존상황급생존시간.결과 Ⅱ조화Ⅲ조대서외주혈균검측출SD대서원성감합체.DTH검사현시대SD대서산생면역내수.간이식결과현시,Ⅰ조대서균재4~5 d사망,이Ⅱ조화Ⅲ조대서1주존활솔위80.0%화84.2%,단Ⅱ조적생존상황불여Ⅲ조.결론 응용7GyTBI+CTX+공체BMT가성공건립동충이체대서감합체모형,유도특이성면역내수,대대제고간이식술후대서적생존상황급생존시간.
Objective To establish the allogeneic animal bone marrow and orthotopic liver transplantation model in rats,and investigate the method and feasibility for enhancing the stability and prolonods:In group Ⅰ,orthotopic liver transplantations in rats were performed using modified Kamada's two-cuff (TBI,11 Gy),and in group Ⅲ,Wistar rats were induced with TBI(7 Gy),followed by infusion of SD kg)intraperitoneally 2 days later.According to the Gene Bank,the specific primer of rat SRY gene was designed.Recipient rats were detected for donor origin cells in the peripheral blood lymphocytes on day 10 and 20 by polyrnerase chain reaction (PCR).The PCR product was analyzed by electrophoresis.Orthotopic liver transplantations were Derformed in rats 28 days later.The tolerance mechanism through delayed type hypersensitivity(DTH)and survival time after liver transplantation in the rats was explored.Results Chimera of SD rats could be found in the peripheral blood lymphocytes of the tolerance Wistar rats in groups Ⅱ and Ⅲ.Wistar rats were specifically tolerant to the SD rats in DTH.The rats in group Ⅰ died after 4-5 days,and the one-week survival rate in groups Ⅱ and Ⅲ was 80% and 84.2% respectively.Conclusion Treatment of 7 Gy TBI and the injection of CTX(50 mg/kg)plus donor bone marrow transplantation(BMT)can successfully establish rat chimera model,induce specific immune tolerance and greatly prolong the survival time of liver transplantation model in rats.